PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Prima Announces New Product Candidate IMP761 -- A LAG-3 Agonist Antibody SYDNEY, AUSTRALIA: ... Prima BioMed Announces First Clinical Data From Combination of IMP321 With Anti-PD1 SYDNEY, AUSTRALIA: ... Marina Biotech to Update Its tkRNAi Clinical Program at Biotech Showcase CITY OF INDUSTRY, CA: ... Atossa Genetics Appoints Jack Cuzick, PhD, FRS, FMedSci, FRCP (hon) as Scientific Advisor SEATTLE, WA: ... Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth TORONTO, ONTARIO: ... Sernova to Present Corporate and JDRF-Sponsored Clinical Trial Update at the Biotech Showcase(TM) 2017 Healthcare Conference in San Francisco LONDON, ONTARIO: ... Prima BioMed Receives UK Approval for AIPAC Study SYDNEY, AUSTRALIA: ... Powerful Marketing Platform and Strong Clinical Trials Results Boost Revenues for Innovus, Says CEO Bassam Damaj SAN DIEGO, CA: ... Prima BioMed Announces ADR Ratio Change SYDNEY, AUSTRALIA: ... IBEX Reports First Quarter Fiscal 2017 Results MONTREAL, QUEBEC: ... Flamel Technologies Doses First Patient in REST-ON Phase III Trial of FT218 for Excessive Daytime Sleepiness & Cataplexy LYON, FRANCE: ... Philippe P. Calais to Join Marina Biotech''s Board of Directors CITY OF INDUSTRY, CA: ... Helix BioPharma Corp. Announces Fiscal First Quarter 2017 Results TORONTO, ONTARIO: ... 2017 Biotech Predictions Foretell Race Towards Cloud, e-Commerce and Greater Transparency PALO ALTO, CA: Bioz Anticipates Industry to "Catch Up" in Adopting Trending Technologies to Accelerate Life Science Research in Year Ahead ... Microbix Arranges New Revolving Credit Facility TORONTO, ONTARIO: Concurrently Renegotiates Terms of Convertible Debentures ... Arch Biopartners Appoints Patrick Vink to Board of Directors TORONTO, CANADA: ... Corcept Therapeutics Announces Encouraging Results of Phase 1/2 Trial of Mifepristone Plus Eribulin in Triple-Negative Breast Cancer MENLO PARK, CA: ... Avid Bioservices to Participate at Upcoming Life Sciences Industry Conferences TUSTIN, CA: ... Sermonix Pharmaceuticals Signs Exclusive Licensing Agreement to Further Explore Lasofoxifene for Breast Cancer Treatment COLUMBUS, OH: Women's oncology pharmaceutical company also raises more than $2 million in preferred seed funding round ... VBI Vaccines Closes $23.6 Million Financing from Perceptive Advisors CAMBRIDGE, MASSACHUSETTS: ... Page 19 von 247: 1 « .. 18 19 20 21 22 23 24 25 26 27 .. » 247